Brief: Codiak Says Sarepta Notified It Was Terminating Early Research License & Option Deal
07/10/2021 22:13
Oct 7 (Reuters) - Codiak BioSciences, Inc. CDAK.O :
* CODIAK BIOSCIENCES - SAREPTA THERAPEUTICS NOTIFIED CO THAT
IT
WAS TERMINATING EARLY TWO-YEAR RESEARCH LICENSE & OPTION
AGREEMENT
* CODIAK BIOSCIENCES - TERMINATION WILL BE EFFECTIVE AS OF
DECEMBER 3, 2021
Further company coverage: CDAK.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Codiak BioSciences,.
See all newsBrief: Codiak Biosciences Notice From Listing Qualifications Department Of Nasdaq Trading Of Co's Common Stock To Be Suspended At Opening Of Business On April 5
U.S. STOCKS ON THE MOVE-Energy firms, crypto stocks, Walt Disney
U.S. STOCKS ON THE MOVE-Cyclerion, banks, Jounce Therapeutics
U.S. STOCKS ON THE MOVE-Tesla, BrainStorm, Pinterest
Codiak BioSciences down after co files for Chapter 11 bankruptcy